60 Degrees Pharmaceuticals Inc Wt

NASDAQ • Healthcare • Biotechnology • Quote as of 10/26/2026

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeNASDAQ

Market Capitalization4.4 mln

Earnings Date11/13/2026

Piotroski F-Score

2 / 9

Weak

Beneish M-Score

0.2

Highly suspicious

Relative Strength

80 / 100

Strongly outperforming

Debt / Equity

0.06

Debt-free

Pre-Tax Margin

-668%

Severely loss-making

ROE

-228

Deeply negative

Key Fundamentals

EPS-11.10

ROE-228

ROIC-561

ROA-148

EBITDA, mln1.55

Revenue, mln1.11

Quote Details

Last 0.026

Change 0 (0%)

Open 0.026

Volume 100

Turnover 2.6

Average Volume 5,508

Financial Ratios

Pre-Tax Profit Margin-668

Current Ratio2.33

Debt / Equity0.06

Price / Sales1.23

Financial Strength

Altman Z-Score-20.94

Piotroski F-Score 2 / 9

Beneish M-Score0.2

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	15.81%	97 / 100
1 Month	-29.16%	14 / 100
2 Months	-49.81%	10 / 100
6 Months	-49.32%	14 / 100
1 Year	14.04%	71 / 100